Schweisberger, C., Jacobson, J. D., & Paprocki, E. (2021). Metreleptin and Metformin Use in an Infant With Congenital Generalized Lipodystrophy Secondary to AGPAT2 Mutation. J Endocr Soc.
Chicago Style CitationSchweisberger, Cintya, Jill Diane Jacobson, and Emily Paprocki. "Metreleptin and Metformin Use in an Infant With Congenital Generalized Lipodystrophy Secondary to AGPAT2 Mutation." J Endocr Soc 2021.
MLA CitationSchweisberger, Cintya, Jill Diane Jacobson, and Emily Paprocki. "Metreleptin and Metformin Use in an Infant With Congenital Generalized Lipodystrophy Secondary to AGPAT2 Mutation." J Endocr Soc 2021.
Warning: These citations may not always be 100% accurate.